
Tariff uncertainties to pose little impact on CIMB's FY2026: Group CEO
This will be due to the group's diversified income strategy and sustainable operational efficiency.
CIMB Group chief executive officer Novan Amirudin said while global tariffs could potentially weigh on regional economic growth, the impact on the bank remains limited and largely depends on how the additional costs are distributed along the supply chain.
"It depends on whether the costs are borne by producers in Asean, consumers in the United States, or absorbed by governments through incentives and supportive policies," he said during a fireside chat held in conjunction with CIMB's Asean Media Day today.
He added that if restrictions on exports from China to the United States prompt manufacturers to relocate to Asean, any resulting oversupply could put pressure on local producers.
"This situation could slow regional growth and indirectly affect the financial sector, as loan growth is closely tied to economic activity," he explained.
Nevertheless, he said CIMB does not rely solely on interest income but has also strengthened its non-interest income streams.
"About 30 per cent of the group's income comes from non-interest sources, including transaction fees, foreign exchange, payment solutions and advisory services.
"These initiatives are aligned with our Forward 30 strategy, which emphasises revenue stream diversification," he said.
On the recent Overnight Policy Rate (OPR) cut by Bank Negara Malaysia, he said the move impacts the lending rates offered to customers.
CIMB also adjusted its deposit rates, such as fixed deposits, which are now at lower levels.
"A lower OPR typically reduces funding costs. Therefore, the net impact on the bank depends on how much lending and deposit rates are adjusted.
"If we are able to reduce deposit rates further, we can still maintain our net interest margins," he said.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Star
2 days ago
- The Star
CIMB remains an attractive defensive play
HLIB Research said CIMB remains the least expensive banking stock in its coverage. PETALING JAYA: CIMB Group Holdings Bhd continues to be a favoured banking stock following the within-expectations financial performance of its Indonesian subsidiary, PT Bank CIMB Niaga Tbk, which released its financial results for the second quarter ended June 30 (2Q) on Wednesday. Hong Leong Investment Bank (HLIB) Research said CIMB Niaga's 1.4% growth in net profit for the first half of financial year ending Dec 31, 2025 (1H25) compared to 1H24 was within expectations and accounted for 49% of both its and the market's full-year forecasts. CIMB Niaga contributes around 20% to 25% of CIMB Group's pre-tax profit. The research house has maintained a 'buy' call on CIMB with an unchanged target price (TP) of RM8.80. Noting that the risk-reward profile for the stock skews favourable, it said CIMB remains the least expensive banking stock in its coverage, trading at an attractive 0.91 times financial year 2026 (FY26) price-to-book while offering a solid 6% dividend yield. TA Research noted that CIMB Niaga continues to demonstrate strong cost discipline in 1H25, with a controlled increase in personnel expenses, up 3.6% in 2Q compared to the same quarter a year ago and 4.3% reduction in other expenses. There was broad-based loan growth led by auto loans as well as unsecured loans and loans to small medium enterprises. Deposit growth was also strong, driven by current and savings accounts. It has reiterated a 'buy' call on parent CIMB with an unchanged TP of RM8.86 pending the release of its 2Q results soon.


The Star
3 days ago
- The Star
CIMB partners Remedi to develop financial solutions for healthcare SMEs
From left: Gurdip Singh Sidhu, CEO, CIMB Malaysia and CIMB Bank; Lawrence Loh, co-CEO, group commercial and transaction banking, CIMB Group; Dr Khairul Faizi Khalid, managing director, Remedi; and Muhamad Faris Ashraf Md Nasser, chief technology officer; at the MoU signing between CIMB and Remedi Innovations to co-develop digital health and wellness solutions aimed at empowering health tech SMEs KUALA LUMPUR: CIMB Bank Bhd has inked a memorandum of understanding with Remedi Innovations Sdn Bhd to co-develop digital health and wellness solutions for health tech small and medium enterprises (SME). Remedi is a certified provider of Electronic Medical Records (EMR) and digital health solutions, which offers a cloud-based clinic management system that enables healthcare providers to optimise clinic operations and enhance patient care. In a stament, the bank said the partnership was formed as part of CIMB's Digital Labs Innovation Programme, and was designed to embed financial services within the digital platforms used by SMEs. Through this collaboration, CIMB and Remedi will co-develop embedded financial solutions directly within Remedi's digital infrastructure that is tailored to the needs of Remedi's clients – which includes clinics, healthcare providers and pharmaceutical suppliers. With the roll-out, the bank said it plans to on board more digital providers nationwide to accelerate the growth of the health-tech industry. "Healthcare is a high-potential growth sector in Malaysia, and we see significant opportunity to support its digital transformation. "Through this partnership, we aim to help healthcare SMEs streamline operations, improve financial management and ultimately, focus on delivering better care," said CIMB Group commercial and transaction banking co-ceo Lawrence Loh in a statement. Remedi Innovations managing director Dr Khairul Faizi Khalid said by removing the complexity of managing separate financial and operational systems, they are enabling healthcare providers to focus entirely on what they do best – caring for their patients. "This collaboration transforms how healthcare SMEs operate, offering them the convenience of streamlined procurement, payments, and business management tools within the ecosystem they already trust."

Barnama
3 days ago
- Barnama
CIMB signs MOU with Remedi to accelerate digital transformation for healthcare SMEs
KUALA LUMPUR, July 31 (Bernama) -- CIMB Bank Berhad ('CIMB' or 'the Bank') has signed a MOU with Remedi Innovations Sdn. Bhd. ('Remedi') to co-develop digital health and wellness solutions for health tech small and medium enterprises ('SMEs'). This strategic partnership positions CIMB as both an ecosystem enabler and innovation partner, driving technology-led financial solutions across high-growth sectors. Formed as part of CIMB's Digital Labs Innovation Programme ('the Programme'), this is designed to embed financial services within the digital platforms used by SMEs. The Programme underscores CIMB's commitment to innovation-led growth by delivering practical, sector-specific financial solutions tailored to business needs within established ecosystems. that meet businesses' needs within established ecosystems. Remedi is a certified provider of Electronic Medical Records ('EMR') and digital health solutions which offers a cloud-based clinic management system that enables healthcare providers to optimise clinic operations and enhance patient care. Through this collaboration, CIMB and Remedi will co-develop embedded financial solutions directly within Remedi's digital infrastructure that is tailored to the needs of Remedi's clients – which includes clinics, healthcare providers and pharmaceutical suppliers. With the roll-out, the Bank plans to on board more digital providers nationwide to accelerate the growth of the health-tech industry.